Iovance Biotherapeutics’ (IOVA) Market Perform Rating Reiterated at JMP Securities
JMP Securities reaffirmed their market perform rating on shares of Iovance Biotherapeutics (NASDAQ:IOVA – Free Report) in a report published on Friday morning,Benzinga reports. A number of other analysts have also recently issued reports on IOVA. Chardan Capital cut their target price on shares of Iovance Biotherapeutics from $30.00 to $25.00 and set a “buy” […]
JMP Securities reaffirmed their market perform rating on shares of Iovance Biotherapeutics (NASDAQ:IOVA – Free Report) in a report published on Friday morning,Benzinga reports. A number of other analysts have also recently issued reports on IOVA. Chardan Capital cut their target price on shares of Iovance Biotherapeutics from $30.00 to $25.00 and set a “buy” […]
